Cargando…

The effect of NR4A1 on APP metabolism and tau phosphorylation

Alzheimer's disease (AD) is characterized by senile plaques (SP) composed of β-amyloid protein (Aβ) and neurofibrillary tangles (NFTs) composed of intracellular hyperphosphorylated tau. Recently, nuclear receptor subfamily 4 group A member 1 (NR4A1) was implicated in synaptic plasticity, long-t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Li-Ge, Tang, Ying, Tan, Jia-Ze, Wang, Jing-Wen, Chen, Guo-Jun, Zhu, Bing-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304284/ https://www.ncbi.nlm.nih.gov/pubmed/30591936 http://dx.doi.org/10.1016/j.gendis.2018.04.008

Ejemplares similares

Abeta is prerequisite, but insufficient to cause tau phosphorylation in vivo: tau phosphorylation in APP mice by diabetes
por: Sato, Naoyuki
Publicado: (2013)

Agomelatine Prevents Amyloid Plaque Deposition, Tau Phosphorylation, and Neuroinflammation in APP/PS1 Mice
por: Yang, Xiao-bo, et al.
Publicado: (2022)

Blockade of NR2A-Containing NMDA Receptors Induces Tau Phosphorylation in Rat Hippocampal Slices
por: Allyson, Julie, et al.
Publicado: (2010)

Nr4a1 promotes renal interstitial fibrosis by regulating the p38 MAPK phosphorylation
por: Tao, Yilin, et al.
Publicado: (2023)

NMDA Reduces Tau Phosphorylation in Rat Hippocampal Slices by Targeting NR2A Receptors, GSK3β, and PKC Activities
por: De Montigny, Audrée, et al.
Publicado: (2013)

CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer’s Disease
por: Shentu, Yang-Ping, et al.
Publicado: (2018)

Tyrosine Phosphorylation of NR2B Contributes to Chronic Migraines via Increased Expression of CGRP in Rats
por: Liang, Xiping, et al.
Publicado: (2017)

Spinal cord NR1 serine phosphorylation and NR2B subunit suppression following peripheral inflammation
por: Caudle, Robert M, et al.
Publicado: (2005)

APP Metabolism Regulates Tau Proteostasis in Human Cerebral Cortex Neurons
por: Moore, Steven, et al.
Publicado: (2015)

The secreted APP ectodomain sAPPα, but not sAPPβ, protects neurons against Aβ oligomer-induced dendritic spine loss and increased tau phosphorylation
por: Tackenberg, Christian, et al.
Publicado: (2019)

NR3C2 inhibits the proliferation of colorectal cancer via regulating glucose metabolism and phosphorylating AMPK
por: Liu, Hui, et al.
Publicado: (2023)

Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology
por: Zhang, Shengnan, et al.
Publicado: (2022)

The Evolution of Tau Phosphorylation and Interactions
por: Trushina, Nataliya I., et al.
Publicado: (2019)

APP processing is regulated by cytoplasmic phosphorylation
por: Lee, Ming-Sum, et al.
Publicado: (2003)

Overexpression of NR4A1 is associated with tumor recurrence and poor survival in non-small-cell lung carcinoma
por: Zhu, Bing, et al.
Publicado: (2017)

Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
por: Shen, Xue-Ning, et al.
Publicado: (2021)

BMP4 overexpression induces the upregulation of APP/Tau and memory deficits in Alzheimer’s disease
por: Zhang, Xiaoqing, et al.
Publicado: (2021)

Therapeutic potential of NR4A1 in cancer: Focus on metabolism
por: Deng, Shan, et al.
Publicado: (2022)

ECFA Newsletter Nr4
Publicado: (2019)

Symphonien Nr. 3 & 4
por: Schubert, Franz, 1797-1828
Publicado: (1988)

Hahnemanns Krankenjournal Nr.4
por: Winder, Marianne
Publicado: (1969)

In-Cell NMR Study of Tau and MARK2 Phosphorylated Tau
por: Zhang, Shengnan, et al.
Publicado: (2018)

Retraction: Overexpression of NR4A1 is associated with tumor recurrence and poor survival in non-small-cell lung carcinoma
por: Zhu, Bing, et al.
Publicado: (2023)

Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease
por: Yu, Chao-Chao, et al.
Publicado: (2019)

AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo
por: Domise, Manon, et al.
Publicado: (2016)

The Physiological Link between Metabolic Rate Depression and Tau Phosphorylation in Mammalian Hibernation
por: Stieler, Jens T., et al.
Publicado: (2011)

The unfolded protein response mediates reversible tau phosphorylation induced by metabolic stress
por: van der Harg, J M, et al.
Publicado: (2014)

The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease
por: Zhao, Juanjuan, et al.
Publicado: (2017)

AMI, an Indazole Derivative, Improves Parkinson’s Disease by Inhibiting Tau Phosphorylation
por: Mao, Zhang, et al.
Publicado: (2020)

Trillium tschonoskii maxim extract attenuates abnormal Tau phosphorylation
por: Luo, Hong-Bin, et al.
Publicado: (2018)

Tau Phosphorylation, Aggregation, and Cell Toxicity
por: Avila, J., et al.
Publicado: (2006)

Propofol Directly Increases Tau Phosphorylation
por: Whittington, Robert A., et al.
Publicado: (2011)

The Importance of Tau Phosphorylation for Neurodegenerative Diseases
por: Noble, Wendy, et al.
Publicado: (2013)

Modulation of tau phosphorylation by environmental copper
por: Voss, Kellen, et al.
Publicado: (2014)

Tau expression and phosphorylation in enteroendocrine cells
por: Chapelet, Guillaume, et al.
Publicado: (2023)

Phosphorylated Tau 181 Serum Levels Predict Alzheimer’s Disease in the Preclinical Stage
por: Qin, Wei, et al.
Publicado: (2022)

Nuclear receptors of NR1 and NR4 subfamilies in the regulation of microglial functions and pathology
por: Katsuki, Hiroshi
Publicado: (2021)

TTBK2: A Tau Protein Kinase beyond Tau Phosphorylation
por: Liao, Jung-Chi, et al.
Publicado: (2015)

Structural Basis of Tau Interaction With BIN1 and Regulation by Tau Phosphorylation
por: Lasorsa, Alessia, et al.
Publicado: (2018)

Extracellular association of APP and tau fibrils induces intracellular aggregate formation of tau
por: Takahashi, Muneaki, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3dif05m89m51q1c9avjsmbgs2c